125 related articles for article (PubMed ID: 6296002)
41. [Therapeutic effect of ceftizoxime on severe infectious complications in blood disorders. Tohkai Research Group on Infections in Hematopoietic Disorders].
Shimizu S; Hirano M; Shirakawa S; Minami N; Ohno R; Murase T; Yamamoto M; Mitomo Y; Yamada K; Shiku H
Jpn J Antibiot; 1984 Dec; 37(12):2494-505. PubMed ID: 6098742
[TBL] [Abstract][Full Text] [Related]
42. [Clinical studies on ceftizoxime in children (author's transl)].
Kobayashi Y; Haruta T; Tsutsui T; Kuroki S; Okura K; Tsuji S; Ouchi T; Yamakawa M
Jpn J Antibiot; 1982 Jan; 35(1):137-51. PubMed ID: 6279905
[No Abstract] [Full Text] [Related]
43. [Clinical studies of ceftizoxime suppositories in the pediatric field].
Sunakawa K; Hirota A; Saito N; Ishizuka Y
Jpn J Antibiot; 1985 Oct; 38(10):2889-95. PubMed ID: 3866082
[TBL] [Abstract][Full Text] [Related]
44. Human cerebrospinal fluid pharmacokinetics and treatment of bacterial meningitis with ceftizoxime.
Cable D; Edralin G; Overturf GD
J Antimicrob Chemother; 1982 Nov; 10 Suppl C():121-7. PubMed ID: 6295997
[No Abstract] [Full Text] [Related]
45. [Clinical and pharmacokinetic evaluations of ceftizoxime suppositories in children].
Meguro H; Mashiko J; Shinozaki T; Fujii R
Jpn J Antibiot; 1985 Oct; 38(10):2838-48. PubMed ID: 3866079
[TBL] [Abstract][Full Text] [Related]
46. [Relation between concentrations of ceftizoxime in bile and the gallbladder wall and blood levels and clinical application of the drug to surgical patients].
Ferri O; Bagni CM; Marinoni M; Fumagalli G; Fanfani A; Meinardi G
G Ital Chemioter; 1984; 31(1-2):121-5. PubMed ID: 6088337
[No Abstract] [Full Text] [Related]
47. [Review [New antibiotics series VI]: Ceftizoxime (author's transl)].
Shimizu K; Shimada J
Jpn J Antibiot; 1982 Apr; 35(4):869-83. PubMed ID: 6285027
[No Abstract] [Full Text] [Related]
48. A pilot study of cefotiam (Ceradolan) in the treatment of lower respiratory tract infections.
Tan TH; Feng PH
Singapore Med J; 1986 Apr; 27(2):125-7. PubMed ID: 3462919
[No Abstract] [Full Text] [Related]
49. [Fundamental and clinical studies of ceftizoxime in pediatric infections (author's transl)].
Ogawa A; Aso K; Miyachi Y; Nishikawa K; Yafuso M; Kuno K
Jpn J Antibiot; 1982 Jan; 35(1):152-9. PubMed ID: 6279906
[TBL] [Abstract][Full Text] [Related]
50. Comparison of ceftizoxime and penicillin for the treatment of uncomplicated gonorrhoea.
Lutz B; Mogabgab WJ; Parks D; Pauling B; Beville R
J Antimicrob Chemother; 1982 Nov; 10 Suppl C():229-35. PubMed ID: 6296012
[No Abstract] [Full Text] [Related]
51. Summary of comparative clinical studies of ceftizoxime and cefamandole, cefazolin and tobramycin.
Duma RJ
J Antimicrob Chemother; 1982 Nov; 10 Suppl C():303-9. PubMed ID: 6296025
[No Abstract] [Full Text] [Related]
52. [Clinical experience with ceftizoxime suppositories in bacterial infections in children].
Hosoda T; Masuda M; Ichioka T; Miyao M; Kamada K; Yuasa Y; Uyama Y; Tanaka H
Jpn J Antibiot; 1985 Oct; 38(10):2952-61. PubMed ID: 3866088
[TBL] [Abstract][Full Text] [Related]
53. The activity of ceftizoxime in combination with gentamicin against hospital isolates of gentamicin-susceptible and resistant Gram-negative bacteria.
Penn RL; King JW
J Antimicrob Chemother; 1982 Nov; 10 Suppl C():51-5. PubMed ID: 6296029
[No Abstract] [Full Text] [Related]
54. Corneal perforation caused by dysgonic fermenter-2.
Kiel RJ; Crane LR; Aguilar J; Palutke WA; Cowden JW
JAMA; 1987 Jun; 257(23):3269-70. PubMed ID: 3473241
[No Abstract] [Full Text] [Related]
55. A randomized clinical trial of ceftizoxime and cefamandole in the treatment of serious lower respiratory tract infections.
Rodriguez J; Vazquez GJ; Bermudez RH; Luina A; Ronda CH
J Antimicrob Chemother; 1982 Nov; 10 Suppl C():209-13. PubMed ID: 6296008
[No Abstract] [Full Text] [Related]
56. [Basic and clinical studies of ceftizoxime suppositories in the pediatric field].
Nishimura T; Tabuki K; Takashima T; Takagi M
Jpn J Antibiot; 1985 Oct; 38(10):2925-31. PubMed ID: 3866086
[TBL] [Abstract][Full Text] [Related]
57. [Fundamental and clinical studies on ceftizoxime in pediatric field (author's transl)].
Iwai N; Taneda Y; Sasaki A; Inokuma K; Mizoguchi F; Nakamura H
Jpn J Antibiot; 1982 Jan; 35(1):47-68. PubMed ID: 6279913
[TBL] [Abstract][Full Text] [Related]
58. Susceptibility of Neisseria gonorrhoeae to ceftizoxime in vitro and in vivo.
Korting HC; Neubert U
Chemotherapy; 1984; 30(5):322-7. PubMed ID: 6092006
[TBL] [Abstract][Full Text] [Related]
59. Cefotaxime: single agent therapy for infections in cancer patients with adequate granulocyte counts.
Rolston K; Bolivar R; Fainstein V; Jones P; Elting L; Bodey GP
J Antimicrob Chemother; 1985 Jan; 15(1):91-6. PubMed ID: 3972760
[TBL] [Abstract][Full Text] [Related]
60. [The clinical evaluation of ceftizoxime suppositories in the pediatric field].
Kuno K; Yafuso M; Hakamada S; Miyachi Y; Nakashima T; Hayakawa F; Nakashima S
Jpn J Antibiot; 1985 Oct; 38(10):2897-902. PubMed ID: 3866083
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
